Paul J Hastings - Net Worth and Insider Trading
Paul J Hastings Net Worth
The estimated net worth of Paul J Hastings is at least $3 Million dollars as of 2024-04-27. Paul J Hastings is the CEO of Nkarta Inc and owns about 390,507 shares of Nkarta Inc (NKTX) stock worth over $3 Million. Paul J Hastings is the Chairman & CEO of OncoMed Pharmaceuticals Inc and owns about 401,028 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $356,915. Paul J Hastings is also the Director of Pacira BioSciences Inc and owns about 6,599 shares of Pacira BioSciences Inc (PCRX) stock worth over $173,752. Besides these, Paul J Hastings also holds Relypsa Inc (RLYP) . Details can be seen in Paul J Hastings's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul J Hastings has not made any transactions after 2024-01-16 and currently still holds the listed stock(s).
Transaction Summary of Paul J Hastings
Paul J Hastings Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul J Hastings owns 6 companies in total, including Nkarta Inc (NKTX) , Pacira BioSciences Inc (PCRX) , and Protara Therapeutics Inc (TARA) among others .
Click here to see the complete history of Paul J Hastings’s form 4 insider trades.
Insider Ownership Summary of Paul J Hastings
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTX | Nkarta Inc | 2024-01-16 | director & See Remarks |
| PCRX | Pacira BioSciences Inc | 2023-06-05 | director |
| TARA | Protara Therapeutics Inc | 2016-10-18 | director |
| OMED | OncoMed Pharmaceuticals Inc | 2017-10-10 | Chairman & CEO |
| RLYP | Relypsa Inc | 2016-09-01 | director |
| NVLNF | Novelion Therapeutics Inc | 2005-04-29 | director & President & CEO |
Paul J Hastings Latest Holdings Summary
Paul J Hastings currently owns a total of 4 stocks. Among these stocks, Paul J Hastings owns 390,507 shares of Nkarta Inc (NKTX) as of January 16, 2024, with a value of $3 Million and a weighting of 81.46%. Paul J Hastings owns 401,028 shares of OncoMed Pharmaceuticals Inc (OMED) as of October 10, 2017, with a value of $356,915 and a weighting of 10.84%. Paul J Hastings also owns 6,599 shares of Pacira BioSciences Inc (PCRX) as of June 5, 2023, with a value of $173,752 and a weighting of 5.28%. The other 1 stocks Relypsa Inc (RLYP) have a combined weighting of 2.42% among all his current holdings.
Latest Holdings of Paul J Hastings
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTX | Nkarta Inc | 2024-01-16 | 390,507 | 6.87 | 2,682,783 |
| OMED | OncoMed Pharmaceuticals Inc | 2017-10-10 | 401,028 | 0.89 | 356,915 |
| PCRX | Pacira BioSciences Inc | 2023-06-05 | 6,599 | 26.33 | 173,752 |
| RLYP | Relypsa Inc | 2016-06-07 | 2,495 | 31.99 | 79,815 |
Holding Weightings of Paul J Hastings
Paul J Hastings Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul J Hastings has made a total of 8 transactions in Nkarta Inc (NKTX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Nkarta Inc is the sale of 9,697 shares on January 16, 2024, which brought Paul J Hastings around $84,752.
According to the SEC Form 4 filings, Paul J Hastings has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the sale of 1,398 shares on October 10, 2017, which brought Paul J Hastings around $5,928.
According to the SEC Form 4 filings, Paul J Hastings has made a total of 7 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 580 shares on June 5, 2023, which brought Paul J Hastings around $22,237.
More details on Paul J Hastings's insider transactions can be found in the Insider Trading History of Paul J Hastings table.Insider Trading History of Paul J Hastings
- 1
Paul J Hastings Trading Performance
GuruFocus tracks the stock performance after each of Paul J Hastings's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul J Hastings is 23.56%. GuruFocus also compares Paul J Hastings's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul J Hastings within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul J Hastings's insider trading performs compared to the benchmark.
Performance of Paul J Hastings
Average Return
157.13%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.98 | 23.56 | 90.94 | 157.13 | 63.12 | 13.9 |
| Relative Return to S&P 500(%) | 3.91 | 23.41 | 82.54 | 144.35 | 50 | 6.64 |
Paul J Hastings Ownership Network
Ownership Network List of Paul J Hastings
Ownership Network Relation of Paul J Hastings
Paul J Hastings Owned Company Details
What does Nkarta Inc do?
Who are the key executives at Nkarta Inc?
Paul J Hastings is the director & See Remarks of Nkarta Inc. Other key executives at Nkarta Inc include 10 percent owner Ra Capital Healthcare Fund Lp , Chief Scientific Officer James Trager , and Chief Medical Officer David Shook .
Nkarta Inc (NKTX) Insider Trades Summary
Over the past 18 months, Paul J Hastings made 3 insider transaction in Nkarta Inc (NKTX) with a net sale of 15,092. Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 10,257 shares made by James Trager , a net sale of 5,497 shares made by David Shook , and a net sale of 6,358 shares made by Alicia J. Hager .
In summary, during the past 3 months, insiders sold 4,143 shares of Nkarta Inc (NKTX) in total and bought 5,000,000 shares, with a net purchase of 4,995,857 shares. During the past 18 months, 42,076 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,957,924 shares.
Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nkarta Inc Insider Transactions
Paul J Hastings Mailing Address
Above is the net worth, insider trading, and ownership report for Paul J Hastings. You might contact Paul J Hastings via mailing address: 61 Hartford Street, San Francisco Ca 94114.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
